Lysergide D-tartrate clinical trials
Also written DT120, MM120 and lysergide tartrate.
A product of Lysergic Acid Diethylamide; its studies count on that page too.
How each study uses lysergide D-tartrate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the lysergide D-tartrate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2025 (2)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Definium Therapeutics US, Inc. (6)
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Lysergic Acid Diethylamide source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1, 1 in phase 3
Studies that test lysergide D-tartrate, phase 3 first.
- Sep 2027A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)Phase 3 · Definium Therapeutics US, Inc.
Studies
Open first, then newest update. How each study uses lysergide D-tartrate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)RecruitingPhase 3Definium Therapeutics US, Inc.NCT07592689Written as DT120
- A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)Active, not recruitingPhase 3Definium Therapeutics US, Inc.NCT06741228Written as DT120
- A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)Active, not recruitingPhase 3Definium Therapeutics US, Inc.NCT06809595Written as DT120
- A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)Active, not recruitingPhase 3Definium Therapeutics US, Inc.NCT06941844Written as DT120
- Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept TrialCompletedPhase 2Definium Therapeutics US, Inc.NCT05200936Written as MM120
- A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety SymptomsCompletedPhase 2Definium Therapeutics US, Inc.NCT05407064Written as MM120
Codes
What other systems call lysergide D-tartrate · ClinicalTrials.gg INT015547
- Wikidata Q27268952lysergide D-tartrateOne source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q27268952 | lysergide D-tartrate | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.